| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAVENOUS | | 772 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION, SOLUTION / INFILTRATION | 0.05 %w/v | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAVENOUS | | 772 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / PARENTERAL | | 30 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAMUSCULAR | | 45 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INFILTRATION | ADJ PH | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / SUBCUTANEOUS | | 25 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / SUBCUTANEOUS | | 25 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SOLUTION / INFILTRATION | ADJ PH | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / SUBCUTANEOUS | | 25 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAMUSCULAR | | 25 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAMUSCULAR | | 25 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | | 45 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERINEURAL | | 80 mg | Exact identifier — unii+route 20 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / PARENTERAL | | 30 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INFILTRATION | | 80 mg | Exact identifier — unii+route 20 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | | 30 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INFILTRATION | 0.02 %w/v | | Exact identifier — unii+route 16 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAVENOUS | | 772 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAMUSCULAR | | 45 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PERINEURAL | | 80 mg | Exact identifier — unii+route 20 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | | 30 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | | 3535 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | | 30 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | | 45 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INFILTRATION | 0.02 %w/v | | Exact identifier — unii+route 16 equally ranked IID candidates |
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | INJECTION, SOLUTION / INFILTRATION | ADJ PH | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / PARENTERAL | | 30 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | INJECTION, SOLUTION / INFILTRATION | | 3535 mg | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAMUSCULAR | | 45 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | | 45 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | | 30 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / PERINEURAL | 0.02 %w/v | | Exact identifier — unii+route 16 equally ranked IID candidates |
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SOLUTION / INFILTRATION | ADJ PH | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / PARENTERAL | | 30 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INFILTRATION | | 80 mg | Exact identifier — unii+route 20 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAMUSCULAR | | 25 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAMUSCULAR | | 25 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAMUSCULAR | | 45 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAVENOUS | | 772 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / PERINEURAL | 0.02 %w/v | | Exact identifier — unii+route 16 equally ranked IID candidates |
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | | 45 mg | Exact identifier — unii+dosage form 20 equally ranked IID candidates |
| SODIUM METABISULFITE | SODIUM METABISULFITE | 4VON5FNS3C | INJECTION, SOLUTION / INFILTRATION | 0.05 %w/v | | Exact identifier — unii+route+dosage form 2 equally ranked IID candidates |
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / SUBCUTANEOUS | | 25 mg | Exact identifier — unii+dosage form 16 equally ranked IID candidates |